Skip to content

Mycoplasma pneumoniae P1 Antigen BA127VSP1



  • Virion/Serion Immunologics Antigen for research use (RUO)
  • Mycoplasma pneumoniae P1 Antigen, recombinant
  • Suitable for detection of IgA, IgG & IgM antibodies in ELISA
  • Lot specific concentration, specified in mg/mL
  • 1 mg
Weight1 lbs
Dimensions9 × 5 × 2 in

Mycoplasma pneumoniae P1

species reactivity

Mycoplasma pneumoniae



assay type

Indirect & quantitative

available size

1 mg

Available product – Mycoplasma pneumoniae P1 Antigen BA127VSP1

Research area
Infectious Disease
Store at -65°C or lower. Avoid repeated freeze-thaw cycles. 10 years from date of manufacture (under recommended storage conditions).
Associated products
Mycoplasma pneumoniae Antigen (BA127VS)
Mycoplasma pneumoniae P1 Antigen (BA127VSP1)
Mycoplasma pneumoniae IgA Control Serum (BC127A)
Mycoplasma pneumoniae IgG Control Serum (BC127G)
Mycoplasma pneumoniae IgM Control Serum (BC127M)
Mycoplasma pneumoniae IgA ELISA Kit (ESR127A)
Mycoplasma pneumoniae IgG ELISA Kit (ESR127G)
Mycoplasma pneumoniae IgM ELISA Kit (ESR127M)
target relevance
Mycoplasma pneumoniae
Structure and strains
Mycoplasma pneumoniae is a very small bacterium in the class Mollicutes. It is a human pathogen that causes the disease mycoplasma pneumonia, a form of atypical bacterial pneumonia related to cold agglutinin disease. M. pneumoniae is characterized by the absence of a peptidoglycan cell wall and resulting resistance to many antibacterial agents. The persistence of M. pneumoniae infections even after treatment is associated with its ability to mimic host cell surface composition.
Mycoplasma pneumoniae is a worldwide distributed bacterium, which is not surrounded by a rigid cell wall. With a diameter of 0.2 µm, the organism belonging to the class of Mollicutes is one of the smallest human pathogens. It possesses a special organelle that allows attachment to the ciliated epithelium in the respiratory tract. The adhesion is mediated by the highly immunogenic P1-Adhesin (168 kDa).

Mycoplasma pneumoniae is the most important causative agent of atypical pneumonia. Despite the high seroprevalence, 10- 15% of all pneumonias are caused by this pathogen. Children and elderly people are particular at risk of Mycoplasma pneumoniae infection, which may manifest with tracheobronchitis, laryngitis, meningitis and otitis media. Furthermore, disorders of the haematopoietic system, the central nervous system and the cardiovascular system can occur.
Detection and diagnosis
The variety of clinical symptoms of atypical pneumonias and possible causative agents requires a diagnosis that is not exclusively limited to the clinical picture. Serological and direct detection methods can be employed to identify the pathogen and so enable appropriate medical intervention strategies. The direct detection of Mycoplasma pneumoniae by cultivation is difficult and time-consuming. Faster results are achieved by complement fixation tests (CFT). Meanwhile, sensitive and specific ELISA tests are available in order to differentiate between immunoglobulin classes so improving the diagnostic value of the results obtained.



Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.



relevant to this product
BA127VSP1 protocol


Product data sheet


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.